MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Ovarian cancer diagnosis and treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,301 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,301 works in the cohort · of 4,299,418page 16 of 47

Labels cover 7 of 2,301 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,301 of 2,301 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Épidémiologie des tumeurs ovariennes présumées bénignes
Camille Mimoun, Xavier Fritel, A. Fauconnier, X. Deffieux, Alexandre Dumont, Cyrille Huchon
2013· review· fr· Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction· Medicine
machine prediction:candidate · noneconsensus · none
23
citations
affvenueunlabeled
The optimal time for surgery in women with serous ovarian cancer
Jocelyn M. Stewart, Alicia Tone, Haiyan Jiang, Marcus Q. Bernardini, Sarah E. Ferguson, Stéphane Laframboise +3 more
2016· article· en· Canadian Journal of Surgery· Medicine
machine prediction:candidate · noneconsensus · none
22
citations
affunlabeled
ENGOT-OV44/FIRST study: A randomized, double-blind, adaptive, phase III study of platinum-based therapy with dostarlimab (TSR-042) + niraparib versus standard-of-care (SOC) platinum-based therapy as first-line treatment of stage 3/4 non-mucinous epithelial ovarian cancer (OC).
Anne‐Claire Hardy‐Bessard, Kathleen N. Moore, Mansoor Raza Mirza, Bernard Asselain, Andrés Redondo, Jacobus Pfisterer +14 more
2019· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
22
citations
affno abstractunlabeled
Early-Stage Endometrioid Ovarian Carcinoma
Aalok Kumar, Nhu D. Le, Anna V. Tinker, Jennifer L. Santos, Christina Parsons, Paul Hoskins
2014· article· en· International Journal of Gynecological Cancer· Medicine
machine prediction:candidate · noneconsensus · none
21
citations

How this was built: Screen · Findings · About